NILE, NCT01366131 / 2011-000711-85: Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease |
|
|
| Completed | 2 | 104 | US, Europe, RoW | MEGF0444A, bevacizumab, carboplatin, paclitaxel, placebo | Genentech, Inc. | Non-Squamous Non-Small Cell Lung Cancer | 02/13 | | | |